Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
+0.72%
N225
+1.43%
AXJO
-0.43%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
76.88M
Dividend Yield
0.00%
P/E Ratio
-4.85
EPS
-0.38
Revenue
35.59M
Avg. Volume
334.93K

Recently from Cashu

publisher logo
Cashu

Mixed Analyst Sentiment on Cytosorbents (CTSO) Highlights Opportunities and Risks in Biotechnology

2 days ago

About

What does CTSO do?
CytoSorbents, headquartered in Princeton, New Jersey, specializes in blood purification technology and critical care immunotherapy, employing 186 people since its IPO on June 17, 2005. Its flagship product, CytoSorb, addresses cytokine storms in critical illnesses, with additional products like VetResQ and various candidates under development.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
New Jersey, USA
Website
http://www.cytosorbents.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
ctso
Cytosorbents
CTSO
+0.05 (+4.24%)
1.23
USD
At close at Jun 27, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials